SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Third Harmonic Bio, Inc. (THRD) trades at a trailing P/E of 4.9. Trailing earnings yield is 20.24%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (4.9); analyst target implies upside (+200.2%); earnings yield beats bond yields (20.24%).
- Trailing Earnings Yield 20.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $16.15 (+200.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 66/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — THRD
Valuation Multiples
P/E (TTM)4.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.09
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield20.24%
Dividend Yield0.00%
Analyst Target$16.15 (+200.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$-0.33 |
$0.00 |
$-12.81M |
- |
| 2021 |
$-0.77 |
$0.00 |
$-29.61M |
- |
| 2022 |
$-0.96 |
$0.00 |
$-37.71M |
- |
| 2023 |
$-0.78 |
$0.00 |
$-30.82M |
- |
| 2024 |
$1.09 |
$0.00 |
$45.47M |
- |
